nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—HTR1B—cranial nerve—Paget's disease of bone	0.0113	0.228	CbGeAlD
Eletriptan—HTR1D—cranial nerve—Paget's disease of bone	0.011	0.221	CbGeAlD
Eletriptan—HTR7—cranial nerve—Paget's disease of bone	0.00875	0.176	CbGeAlD
Eletriptan—CYP2C19—urine—Paget's disease of bone	0.00635	0.127	CbGeAlD
Eletriptan—CYP2C9—urine—Paget's disease of bone	0.00492	0.0988	CbGeAlD
Eletriptan—CYP3A4—urine—Paget's disease of bone	0.00375	0.0754	CbGeAlD
Eletriptan—CYP2D6—urine—Paget's disease of bone	0.00369	0.0742	CbGeAlD
Eletriptan—Abdominal discomfort—Risedronate—Paget's disease of bone	0.00317	0.00334	CcSEcCtD
Eletriptan—Influenza—Pamidronate—Paget's disease of bone	0.00315	0.00331	CcSEcCtD
Eletriptan—Anaemia—Etidronic acid—Paget's disease of bone	0.00312	0.00328	CcSEcCtD
Eletriptan—Angioedema—Etidronic acid—Paget's disease of bone	0.00308	0.00324	CcSEcCtD
Eletriptan—Abdominal pain upper—Zoledronate—Paget's disease of bone	0.00304	0.0032	CcSEcCtD
Eletriptan—Leukopenia—Etidronic acid—Paget's disease of bone	0.00302	0.00318	CcSEcCtD
Eletriptan—Cramp muscle—Zoledronate—Paget's disease of bone	0.003	0.00315	CcSEcCtD
Eletriptan—Gastritis—Zoledronate—Paget's disease of bone	0.00294	0.0031	CcSEcCtD
Eletriptan—Muscular weakness—Zoledronate—Paget's disease of bone	0.00293	0.00309	CcSEcCtD
Eletriptan—Alopecia—Alendronate—Paget's disease of bone	0.00292	0.00307	CcSEcCtD
Eletriptan—Abdominal distension—Zoledronate—Paget's disease of bone	0.00289	0.00305	CcSEcCtD
Eletriptan—Dysphagia—Zoledronate—Paget's disease of bone	0.00287	0.00303	CcSEcCtD
Eletriptan—Asthma—Zoledronate—Paget's disease of bone	0.00287	0.00303	CcSEcCtD
Eletriptan—Influenza—Zoledronate—Paget's disease of bone	0.00287	0.00303	CcSEcCtD
Eletriptan—Arthralgia—Etidronic acid—Paget's disease of bone	0.00287	0.00302	CcSEcCtD
Eletriptan—Conjunctivitis—Risedronate—Paget's disease of bone	0.00287	0.00302	CcSEcCtD
Eletriptan—Discomfort—Etidronic acid—Paget's disease of bone	0.00284	0.00299	CcSEcCtD
Eletriptan—Flatulence—Alendronate—Paget's disease of bone	0.00283	0.00298	CcSEcCtD
Eletriptan—Dysgeusia—Alendronate—Paget's disease of bone	0.00282	0.00296	CcSEcCtD
Eletriptan—Confusional state—Etidronic acid—Paget's disease of bone	0.00278	0.00292	CcSEcCtD
Eletriptan—Sinusitis—Risedronate—Paget's disease of bone	0.00277	0.00291	CcSEcCtD
Eletriptan—Muscle spasms—Alendronate—Paget's disease of bone	0.00276	0.00291	CcSEcCtD
Eletriptan—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.00276	0.0029	CcSEcCtD
Eletriptan—Stomatitis—Pamidronate—Paget's disease of bone	0.00274	0.00288	CcSEcCtD
Eletriptan—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00273	0.00287	CcSEcCtD
Eletriptan—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00267	0.00281	CcSEcCtD
Eletriptan—Anaemia—Alendronate—Paget's disease of bone	0.00266	0.0028	CcSEcCtD
Eletriptan—Rhinitis—Risedronate—Paget's disease of bone	0.00266	0.0028	CcSEcCtD
Eletriptan—Pollakiuria—Zoledronate—Paget's disease of bone	0.00266	0.00279	CcSEcCtD
Eletriptan—Sinusitis—Pamidronate—Paget's disease of bone	0.00263	0.00277	CcSEcCtD
Eletriptan—Pharyngitis—Risedronate—Paget's disease of bone	0.00263	0.00277	CcSEcCtD
Eletriptan—Angioedema—Alendronate—Paget's disease of bone	0.00263	0.00276	CcSEcCtD
Eletriptan—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00262	0.00275	CcSEcCtD
Eletriptan—Weight increased—Zoledronate—Paget's disease of bone	0.00262	0.00275	CcSEcCtD
Eletriptan—Oedema peripheral—Risedronate—Paget's disease of bone	0.00261	0.00275	CcSEcCtD
Eletriptan—Weight decreased—Zoledronate—Paget's disease of bone	0.0026	0.00274	CcSEcCtD
Eletriptan—Urethral disorder—Risedronate—Paget's disease of bone	0.0026	0.00273	CcSEcCtD
Eletriptan—Malaise—Alendronate—Paget's disease of bone	0.00259	0.00273	CcSEcCtD
Eletriptan—Vertigo—Alendronate—Paget's disease of bone	0.00258	0.00272	CcSEcCtD
Eletriptan—Rhinitis—Pamidronate—Paget's disease of bone	0.00253	0.00266	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00251	0.00264	CcSEcCtD
Eletriptan—Stomatitis—Zoledronate—Paget's disease of bone	0.0025	0.00263	CcSEcCtD
Eletriptan—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00249	0.00262	CcSEcCtD
Eletriptan—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00249	0.00262	CcSEcCtD
Eletriptan—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00247	0.0026	CcSEcCtD
Eletriptan—Tinnitus—Risedronate—Paget's disease of bone	0.00247	0.0026	CcSEcCtD
Eletriptan—Urethral disorder—Pamidronate—Paget's disease of bone	0.00247	0.0026	CcSEcCtD
Eletriptan—Myalgia—Alendronate—Paget's disease of bone	0.00245	0.00258	CcSEcCtD
Eletriptan—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00242	0.00255	CcSEcCtD
Eletriptan—Discomfort—Alendronate—Paget's disease of bone	0.00242	0.00254	CcSEcCtD
Eletriptan—Immune system disorder—Risedronate—Paget's disease of bone	0.00239	0.00252	CcSEcCtD
Eletriptan—Arrhythmia—Risedronate—Paget's disease of bone	0.00237	0.00249	CcSEcCtD
Eletriptan—Constipation—Etidronic acid—Paget's disease of bone	0.00235	0.00248	CcSEcCtD
Eletriptan—Bradycardia—Zoledronate—Paget's disease of bone	0.00234	0.00247	CcSEcCtD
Eletriptan—Flushing—Pamidronate—Paget's disease of bone	0.00234	0.00246	CcSEcCtD
Eletriptan—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00229	0.00241	CcSEcCtD
Eletriptan—Immune system disorder—Pamidronate—Paget's disease of bone	0.00228	0.00239	CcSEcCtD
Eletriptan—Flatulence—Risedronate—Paget's disease of bone	0.00227	0.00239	CcSEcCtD
Eletriptan—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00227	0.00239	CcSEcCtD
Eletriptan—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00227	0.00239	CcSEcCtD
Eletriptan—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00227	0.00239	CcSEcCtD
Eletriptan—Chills—Pamidronate—Paget's disease of bone	0.00226	0.00238	CcSEcCtD
Eletriptan—Urethral disorder—Zoledronate—Paget's disease of bone	0.00226	0.00237	CcSEcCtD
Eletriptan—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00225	0.00237	CcSEcCtD
Eletriptan—Back pain—Risedronate—Paget's disease of bone	0.00223	0.00235	CcSEcCtD
Eletriptan—Alopecia—Pamidronate—Paget's disease of bone	0.00223	0.00234	CcSEcCtD
Eletriptan—Muscle spasms—Risedronate—Paget's disease of bone	0.00222	0.00233	CcSEcCtD
Eletriptan—Urticaria—Etidronic acid—Paget's disease of bone	0.00219	0.0023	CcSEcCtD
Eletriptan—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00218	0.00229	CcSEcCtD
Eletriptan—Tension—Pamidronate—Paget's disease of bone	0.00215	0.00226	CcSEcCtD
Eletriptan—Dysgeusia—Pamidronate—Paget's disease of bone	0.00215	0.00226	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00214	0.00225	CcSEcCtD
Eletriptan—Flushing—Zoledronate—Paget's disease of bone	0.00214	0.00225	CcSEcCtD
Eletriptan—Anaemia—Risedronate—Paget's disease of bone	0.00213	0.00224	CcSEcCtD
Eletriptan—Nervousness—Pamidronate—Paget's disease of bone	0.00213	0.00224	CcSEcCtD
Eletriptan—Back pain—Pamidronate—Paget's disease of bone	0.00212	0.00223	CcSEcCtD
Eletriptan—Muscle spasms—Pamidronate—Paget's disease of bone	0.00211	0.00222	CcSEcCtD
Eletriptan—Angioedema—Risedronate—Paget's disease of bone	0.00211	0.00222	CcSEcCtD
Eletriptan—Immune system disorder—Zoledronate—Paget's disease of bone	0.00208	0.00219	CcSEcCtD
Eletriptan—Vertigo—Risedronate—Paget's disease of bone	0.00207	0.00218	CcSEcCtD
Eletriptan—Syncope—Risedronate—Paget's disease of bone	0.00207	0.00218	CcSEcCtD
Eletriptan—Dyspepsia—Alendronate—Paget's disease of bone	0.00207	0.00217	CcSEcCtD
Eletriptan—Chills—Zoledronate—Paget's disease of bone	0.00206	0.00217	CcSEcCtD
Eletriptan—Arrhythmia—Zoledronate—Paget's disease of bone	0.00206	0.00216	CcSEcCtD
Eletriptan—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00203	0.00214	CcSEcCtD
Eletriptan—Alopecia—Zoledronate—Paget's disease of bone	0.00203	0.00214	CcSEcCtD
Eletriptan—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00203	0.00214	CcSEcCtD
Eletriptan—Loss of consciousness—Risedronate—Paget's disease of bone	0.00203	0.00213	CcSEcCtD
Eletriptan—Anaemia—Pamidronate—Paget's disease of bone	0.00203	0.00213	CcSEcCtD
Eletriptan—Agitation—Pamidronate—Paget's disease of bone	0.00202	0.00212	CcSEcCtD
Eletriptan—Cough—Risedronate—Paget's disease of bone	0.00201	0.00212	CcSEcCtD
Eletriptan—Pain—Alendronate—Paget's disease of bone	0.00201	0.00211	CcSEcCtD
Eletriptan—Constipation—Alendronate—Paget's disease of bone	0.00201	0.00211	CcSEcCtD
Eletriptan—Angioedema—Pamidronate—Paget's disease of bone	0.002	0.00211	CcSEcCtD
Eletriptan—Hypertension—Risedronate—Paget's disease of bone	0.00199	0.0021	CcSEcCtD
Eletriptan—Malaise—Pamidronate—Paget's disease of bone	0.00198	0.00208	CcSEcCtD
Eletriptan—Syncope—Pamidronate—Paget's disease of bone	0.00197	0.00207	CcSEcCtD
Eletriptan—Myalgia—Risedronate—Paget's disease of bone	0.00196	0.00207	CcSEcCtD
Eletriptan—Arthralgia—Risedronate—Paget's disease of bone	0.00196	0.00207	CcSEcCtD
Eletriptan—Leukopenia—Pamidronate—Paget's disease of bone	0.00196	0.00207	CcSEcCtD
Eletriptan—Dysgeusia—Zoledronate—Paget's disease of bone	0.00196	0.00206	CcSEcCtD
Eletriptan—Anxiety—Risedronate—Paget's disease of bone	0.00196	0.00206	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00195	0.00205	CcSEcCtD
Eletriptan—Pruritus—Etidronic acid—Paget's disease of bone	0.00195	0.00205	CcSEcCtD
Eletriptan—Back pain—Zoledronate—Paget's disease of bone	0.00194	0.00204	CcSEcCtD
Eletriptan—Feeling abnormal—Alendronate—Paget's disease of bone	0.00193	0.00203	CcSEcCtD
Eletriptan—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00193	0.00203	CcSEcCtD
Eletriptan—Muscle spasms—Zoledronate—Paget's disease of bone	0.00193	0.00203	CcSEcCtD
Eletriptan—Dry mouth—Risedronate—Paget's disease of bone	0.00192	0.00202	CcSEcCtD
Eletriptan—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00192	0.00202	CcSEcCtD
Eletriptan—Cough—Pamidronate—Paget's disease of bone	0.00191	0.00201	CcSEcCtD
Eletriptan—Convulsion—Pamidronate—Paget's disease of bone	0.0019	0.002	CcSEcCtD
Eletriptan—Hypertension—Pamidronate—Paget's disease of bone	0.00189	0.00199	CcSEcCtD
Eletriptan—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00188	0.00198	CcSEcCtD
Eletriptan—Tremor—Zoledronate—Paget's disease of bone	0.00188	0.00197	CcSEcCtD
Eletriptan—Arthralgia—Pamidronate—Paget's disease of bone	0.00187	0.00196	CcSEcCtD
Eletriptan—Myalgia—Pamidronate—Paget's disease of bone	0.00187	0.00196	CcSEcCtD
Eletriptan—Urticaria—Alendronate—Paget's disease of bone	0.00186	0.00196	CcSEcCtD
Eletriptan—Anxiety—Pamidronate—Paget's disease of bone	0.00186	0.00196	CcSEcCtD
Eletriptan—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00186	0.00196	CcSEcCtD
Eletriptan—Abdominal pain—Alendronate—Paget's disease of bone	0.00185	0.00195	CcSEcCtD
Eletriptan—Body temperature increased—Alendronate—Paget's disease of bone	0.00185	0.00195	CcSEcCtD
Eletriptan—Shock—Risedronate—Paget's disease of bone	0.00185	0.00195	CcSEcCtD
Eletriptan—Anaemia—Zoledronate—Paget's disease of bone	0.00185	0.00195	CcSEcCtD
Eletriptan—Nervous system disorder—Risedronate—Paget's disease of bone	0.00185	0.00194	CcSEcCtD
Eletriptan—Discomfort—Pamidronate—Paget's disease of bone	0.00184	0.00194	CcSEcCtD
Eletriptan—Agitation—Zoledronate—Paget's disease of bone	0.00184	0.00194	CcSEcCtD
Eletriptan—Angioedema—Zoledronate—Paget's disease of bone	0.00183	0.00193	CcSEcCtD
Eletriptan—Skin disorder—Risedronate—Paget's disease of bone	0.00183	0.00192	CcSEcCtD
Eletriptan—Malaise—Zoledronate—Paget's disease of bone	0.00181	0.0019	CcSEcCtD
Eletriptan—Confusional state—Pamidronate—Paget's disease of bone	0.0018	0.0019	CcSEcCtD
Eletriptan—Vertigo—Zoledronate—Paget's disease of bone	0.0018	0.00189	CcSEcCtD
Eletriptan—Syncope—Zoledronate—Paget's disease of bone	0.0018	0.00189	CcSEcCtD
Eletriptan—Leukopenia—Zoledronate—Paget's disease of bone	0.00179	0.00189	CcSEcCtD
Eletriptan—Oedema—Pamidronate—Paget's disease of bone	0.00179	0.00188	CcSEcCtD
Eletriptan—Palpitations—Zoledronate—Paget's disease of bone	0.00177	0.00186	CcSEcCtD
Eletriptan—Shock—Pamidronate—Paget's disease of bone	0.00176	0.00185	CcSEcCtD
Eletriptan—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00176	0.00185	CcSEcCtD
Eletriptan—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00176	0.00185	CcSEcCtD
Eletriptan—Vomiting—Etidronic acid—Paget's disease of bone	0.00175	0.00184	CcSEcCtD
Eletriptan—Cough—Zoledronate—Paget's disease of bone	0.00175	0.00184	CcSEcCtD
Eletriptan—Tachycardia—Pamidronate—Paget's disease of bone	0.00175	0.00184	CcSEcCtD
Eletriptan—Rash—Etidronic acid—Paget's disease of bone	0.00174	0.00183	CcSEcCtD
Eletriptan—Convulsion—Zoledronate—Paget's disease of bone	0.00174	0.00183	CcSEcCtD
Eletriptan—Dermatitis—Etidronic acid—Paget's disease of bone	0.00173	0.00183	CcSEcCtD
Eletriptan—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00173	0.00182	CcSEcCtD
Eletriptan—Hypertension—Zoledronate—Paget's disease of bone	0.00173	0.00182	CcSEcCtD
Eletriptan—Hypersensitivity—Alendronate—Paget's disease of bone	0.00173	0.00182	CcSEcCtD
Eletriptan—Headache—Etidronic acid—Paget's disease of bone	0.00173	0.00182	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00172	0.00181	CcSEcCtD
Eletriptan—Anorexia—Pamidronate—Paget's disease of bone	0.00171	0.0018	CcSEcCtD
Eletriptan—Arthralgia—Zoledronate—Paget's disease of bone	0.00171	0.00179	CcSEcCtD
Eletriptan—Myalgia—Zoledronate—Paget's disease of bone	0.00171	0.00179	CcSEcCtD
Eletriptan—Insomnia—Risedronate—Paget's disease of bone	0.0017	0.00179	CcSEcCtD
Eletriptan—Anxiety—Zoledronate—Paget's disease of bone	0.0017	0.00179	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00169	0.00178	CcSEcCtD
Eletriptan—Paraesthesia—Risedronate—Paget's disease of bone	0.00169	0.00178	CcSEcCtD
Eletriptan—Discomfort—Zoledronate—Paget's disease of bone	0.00168	0.00177	CcSEcCtD
Eletriptan—Asthenia—Alendronate—Paget's disease of bone	0.00168	0.00177	CcSEcCtD
Eletriptan—Dyspnoea—Risedronate—Paget's disease of bone	0.00168	0.00177	CcSEcCtD
Eletriptan—Hypotension—Pamidronate—Paget's disease of bone	0.00167	0.00176	CcSEcCtD
Eletriptan—Dry mouth—Zoledronate—Paget's disease of bone	0.00167	0.00176	CcSEcCtD
Eletriptan—Pruritus—Alendronate—Paget's disease of bone	0.00166	0.00175	CcSEcCtD
Eletriptan—Dyspepsia—Risedronate—Paget's disease of bone	0.00166	0.00174	CcSEcCtD
Eletriptan—Confusional state—Zoledronate—Paget's disease of bone	0.00165	0.00173	CcSEcCtD
Eletriptan—Nausea—Etidronic acid—Paget's disease of bone	0.00164	0.00172	CcSEcCtD
Eletriptan—Oedema—Zoledronate—Paget's disease of bone	0.00163	0.00172	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00163	0.00172	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00163	0.00171	CcSEcCtD
Eletriptan—Fatigue—Risedronate—Paget's disease of bone	0.00162	0.00171	CcSEcCtD
Eletriptan—Insomnia—Pamidronate—Paget's disease of bone	0.00162	0.0017	CcSEcCtD
Eletriptan—Pain—Risedronate—Paget's disease of bone	0.00161	0.00169	CcSEcCtD
Eletriptan—Constipation—Risedronate—Paget's disease of bone	0.00161	0.00169	CcSEcCtD
Eletriptan—Shock—Zoledronate—Paget's disease of bone	0.00161	0.00169	CcSEcCtD
Eletriptan—Paraesthesia—Pamidronate—Paget's disease of bone	0.00161	0.00169	CcSEcCtD
Eletriptan—Diarrhoea—Alendronate—Paget's disease of bone	0.00161	0.00169	CcSEcCtD
Eletriptan—Nervous system disorder—Zoledronate—Paget's disease of bone	0.0016	0.00169	CcSEcCtD
Eletriptan—Dyspnoea—Pamidronate—Paget's disease of bone	0.0016	0.00168	CcSEcCtD
Eletriptan—Tachycardia—Zoledronate—Paget's disease of bone	0.0016	0.00168	CcSEcCtD
Eletriptan—Somnolence—Pamidronate—Paget's disease of bone	0.00159	0.00167	CcSEcCtD
Eletriptan—Skin disorder—Zoledronate—Paget's disease of bone	0.00159	0.00167	CcSEcCtD
Eletriptan—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00158	0.00166	CcSEcCtD
Eletriptan—Dyspepsia—Pamidronate—Paget's disease of bone	0.00158	0.00166	CcSEcCtD
Eletriptan—Anorexia—Zoledronate—Paget's disease of bone	0.00156	0.00164	CcSEcCtD
Eletriptan—Decreased appetite—Pamidronate—Paget's disease of bone	0.00156	0.00164	CcSEcCtD
Eletriptan—Dizziness—Alendronate—Paget's disease of bone	0.00155	0.00163	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00155	0.00163	CcSEcCtD
Eletriptan—Fatigue—Pamidronate—Paget's disease of bone	0.00154	0.00162	CcSEcCtD
Eletriptan—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00154	0.00162	CcSEcCtD
Eletriptan—Pain—Pamidronate—Paget's disease of bone	0.00153	0.00161	CcSEcCtD
Eletriptan—Constipation—Pamidronate—Paget's disease of bone	0.00153	0.00161	CcSEcCtD
Eletriptan—Hypotension—Zoledronate—Paget's disease of bone	0.00153	0.00161	CcSEcCtD
Eletriptan—Urticaria—Risedronate—Paget's disease of bone	0.0015	0.00157	CcSEcCtD
Eletriptan—Vomiting—Alendronate—Paget's disease of bone	0.00149	0.00157	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00149	0.00157	CcSEcCtD
Eletriptan—Abdominal pain—Risedronate—Paget's disease of bone	0.00149	0.00157	CcSEcCtD
Eletriptan—Body temperature increased—Risedronate—Paget's disease of bone	0.00149	0.00157	CcSEcCtD
Eletriptan—Rash—Alendronate—Paget's disease of bone	0.00148	0.00156	CcSEcCtD
Eletriptan—Insomnia—Zoledronate—Paget's disease of bone	0.00148	0.00156	CcSEcCtD
Eletriptan—Dermatitis—Alendronate—Paget's disease of bone	0.00148	0.00156	CcSEcCtD
Eletriptan—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00147	0.00155	CcSEcCtD
Eletriptan—Headache—Alendronate—Paget's disease of bone	0.00147	0.00155	CcSEcCtD
Eletriptan—Paraesthesia—Zoledronate—Paget's disease of bone	0.00147	0.00154	CcSEcCtD
Eletriptan—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00146	0.00154	CcSEcCtD
Eletriptan—Dyspnoea—Zoledronate—Paget's disease of bone	0.00146	0.00153	CcSEcCtD
Eletriptan—Somnolence—Zoledronate—Paget's disease of bone	0.00145	0.00153	CcSEcCtD
Eletriptan—Dyspepsia—Zoledronate—Paget's disease of bone	0.00144	0.00151	CcSEcCtD
Eletriptan—Decreased appetite—Zoledronate—Paget's disease of bone	0.00142	0.0015	CcSEcCtD
Eletriptan—Body temperature increased—Pamidronate—Paget's disease of bone	0.00141	0.00149	CcSEcCtD
Eletriptan—Abdominal pain—Pamidronate—Paget's disease of bone	0.00141	0.00149	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00141	0.00149	CcSEcCtD
Eletriptan—Fatigue—Zoledronate—Paget's disease of bone	0.00141	0.00148	CcSEcCtD
Eletriptan—Pain—Zoledronate—Paget's disease of bone	0.0014	0.00147	CcSEcCtD
Eletriptan—Constipation—Zoledronate—Paget's disease of bone	0.0014	0.00147	CcSEcCtD
Eletriptan—Nausea—Alendronate—Paget's disease of bone	0.00139	0.00147	CcSEcCtD
Eletriptan—Hypersensitivity—Risedronate—Paget's disease of bone	0.00139	0.00146	CcSEcCtD
Eletriptan—Asthenia—Risedronate—Paget's disease of bone	0.00135	0.00142	CcSEcCtD
Eletriptan—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00135	0.00142	CcSEcCtD
Eletriptan—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00134	0.00141	CcSEcCtD
Eletriptan—Pruritus—Risedronate—Paget's disease of bone	0.00133	0.0014	CcSEcCtD
Eletriptan—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00132	0.00139	CcSEcCtD
Eletriptan—Urticaria—Zoledronate—Paget's disease of bone	0.0013	0.00137	CcSEcCtD
Eletriptan—Abdominal pain—Zoledronate—Paget's disease of bone	0.00129	0.00136	CcSEcCtD
Eletriptan—Body temperature increased—Zoledronate—Paget's disease of bone	0.00129	0.00136	CcSEcCtD
Eletriptan—Diarrhoea—Risedronate—Paget's disease of bone	0.00129	0.00136	CcSEcCtD
Eletriptan—Asthenia—Pamidronate—Paget's disease of bone	0.00128	0.00135	CcSEcCtD
Eletriptan—Pruritus—Pamidronate—Paget's disease of bone	0.00127	0.00133	CcSEcCtD
Eletriptan—Dizziness—Risedronate—Paget's disease of bone	0.00124	0.00131	CcSEcCtD
Eletriptan—Diarrhoea—Pamidronate—Paget's disease of bone	0.00122	0.00129	CcSEcCtD
Eletriptan—Hypersensitivity—Zoledronate—Paget's disease of bone	0.0012	0.00127	CcSEcCtD
Eletriptan—Vomiting—Risedronate—Paget's disease of bone	0.0012	0.00126	CcSEcCtD
Eletriptan—Rash—Risedronate—Paget's disease of bone	0.00119	0.00125	CcSEcCtD
Eletriptan—Dermatitis—Risedronate—Paget's disease of bone	0.00119	0.00125	CcSEcCtD
Eletriptan—Dizziness—Pamidronate—Paget's disease of bone	0.00118	0.00125	CcSEcCtD
Eletriptan—Headache—Risedronate—Paget's disease of bone	0.00118	0.00124	CcSEcCtD
Eletriptan—Asthenia—Zoledronate—Paget's disease of bone	0.00117	0.00123	CcSEcCtD
Eletriptan—Pruritus—Zoledronate—Paget's disease of bone	0.00116	0.00122	CcSEcCtD
Eletriptan—Vomiting—Pamidronate—Paget's disease of bone	0.00114	0.0012	CcSEcCtD
Eletriptan—Rash—Pamidronate—Paget's disease of bone	0.00113	0.00119	CcSEcCtD
Eletriptan—Dermatitis—Pamidronate—Paget's disease of bone	0.00113	0.00119	CcSEcCtD
Eletriptan—Headache—Pamidronate—Paget's disease of bone	0.00112	0.00118	CcSEcCtD
Eletriptan—Diarrhoea—Zoledronate—Paget's disease of bone	0.00112	0.00118	CcSEcCtD
Eletriptan—Nausea—Risedronate—Paget's disease of bone	0.00112	0.00118	CcSEcCtD
Eletriptan—Dizziness—Zoledronate—Paget's disease of bone	0.00108	0.00114	CcSEcCtD
Eletriptan—Nausea—Pamidronate—Paget's disease of bone	0.00106	0.00112	CcSEcCtD
Eletriptan—Vomiting—Zoledronate—Paget's disease of bone	0.00104	0.00109	CcSEcCtD
Eletriptan—Rash—Zoledronate—Paget's disease of bone	0.00103	0.00108	CcSEcCtD
Eletriptan—Dermatitis—Zoledronate—Paget's disease of bone	0.00103	0.00108	CcSEcCtD
Eletriptan—Headache—Zoledronate—Paget's disease of bone	0.00102	0.00108	CcSEcCtD
Eletriptan—Nausea—Zoledronate—Paget's disease of bone	0.000971	0.00102	CcSEcCtD
